Leukemia : Science World Report

Jun 16, 2015 02:57 PM EDT

Avocados May Help Destroy Leukemia Stem Cells

New findings published in the journal Cancer Research reveal that fats in avocados may help fight against acute myeloid leukemia (AML) by destroying leukemia stem cells that can quickly worsen if not treated quickly.

Sep 08, 2014 11:25 AM EDT

Novel Cancer Drug Brings Hope for Leukemia Patients

A new cancer drug was found safe for cancer patients, according to the results of a phase I clinical trial about a new drug targeting mitochondrial function in human cancer cells. Researchers at Wake Forest Baptist Medical Center have discovered that this could be the first drug to inhibit mitochond...

Aug 14, 2014 11:36 AM EDT

Gene Mutations Reveal Biological Workings of Most Common Type of Childhood Leukaemia

Recent findings published in the journal Nature Communications examine recently discovered gene mutations that lead to acute lymphoblastic leukemia--the most common type found in children.

Jun 16, 2014 04:13 PM EDT

Could Unique Lipids Help Fight Leukemia?

Researchers from the University of Basel in Switzerland believe that certain lipid molecules may be helpful in fighting leukemia. A recent study, published in the Journal of Experimental Medicine, shows that certain lipids actually carry the power to kill tumor cells.

Feb 11, 2014 08:49 PM EST

Leukemia Drug Development May Target Specific Protein

Existing treatments for acute myeloid leukemia (AML) are only effective in 20 percent to 40 percent of cases. Now, researchers have found a protein that may exacerbate cases of AML, which could be the next focus of leukemia treatment.

Feb 11, 2014 01:57 PM EST

New Promising Information to Treat, Cure Childhood Leukemias

Researchers from the UT Health Center may have pinpointed a protein that could potentially play a key role in the development of pediatric AML-promising new information to treat and cure possible childhood leukemias.

Aug 15, 2013 03:25 PM EDT

Virus-Derived Particles Target Blood Cancer

Ottawa researchers have developed unique virus-derived particles that can kill human blood cancer cells in the laboratory and eradicate the disease in mice with few side effects.